LYRA™
Feel at ease with LYRA™, the laser treatment made to restore intimate vitality and control. If you struggle with sexual dysfunction, urinary incontinence, vaginal atrophy, or other vaginal concerns, this treatment may be right for you.
The LYRA™ is an adjustable laser speculum with a diameter of 8-28 mm. Compatible to various indications, it supports dependent fibers: Radial, Side Fire, or Flat Fiber to enhance the movement of the fiber.
The LYRA™ applies a diode laser with 1470nm wavelength which is heavily absorbed in water making it ideal for treating the vaginal mucosa to generates a highly effective, deep thermal effect.
WHAT LYRA™ TREATS
LYRA™ presents a quick and painless solution for various feminine indications, including:
- Vaginal tissue remodelling
- Vaginal Atrophy
- SUI (Mild to moderate urinary leakage)
- Genitourinary syndrome of menopause
- Post-Delivery Rehabilitation
- Post-Menopausal Symptoms
HOW LYRA™ WORKS
LYRA™ applies a 1470 nm diode laser delivered through radial fiber which emits 360-degree lasing throughout the vaginal canal allowing physicians to treat the area homogeneously which in turn achieves superior results by delivering optimum energy throughout the Mucosal Layer.
LYRA™ FAQS
How long does the procedure take?
Treatment times are fast but will vary from patient to patient.
Is the procedure painful?
No, LYRA™ doesn’t coagulate or vaporize tissue like CO2 and therefore minimizes the risk of pain, downtime, and possible complications.
Is the procedure painful?
No, LYRA™ doesn’t coagulate or vaporize tissue like CO2 and therefore minimizes the risk of pain, downtime, and possible complications.
Is the treatment efficient?
The 1470 nm diode laser is delivered through a radial fiber which emits 360-degree uniform lasing throughout the vaginal canal. This unique feature allows physicians to treat the area homogeneously thereby achieving effective results by delivering optimum energy throughout the Mucosal Layer in the vaginal canal.
LYRA™ CLINICAL
In clinical trials, patients reported:
- Strong or moderate improvement in vaginal tightness (95% of patients).
- An average 17% shrinkage of the vaginal canal.
- A high level of satisfaction (97% of patients).
* LYRA™ pending FDA clearance in the US.
